The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Replacement of Shire plc

19 Dec 2018 14:41

RNS Number : 0154L
Morgan Stanley Capital Services LLC
19 December 2018
 

AMENDMENT Section 2(b) & 2c(i)

 

 FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley Capital Services LLC

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Shire plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Shire plc

(d) Date dealing undertaken:

17 DECEMBER 2018

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes - Takeda Pharmaceutical Company Limited

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 The currency of all prices and other monetary amounts should be stated.

 

 

(a) Purchases and sales

 

 Class of

relevant

security

 Purchases/

sales

 Total number

of securities

 Highest price

per unit paid/received

 Lowest price

per unit paid/received

 ADR

 PURCHASES

 8

 171.1300 USD

 169.0300 USD

 

 ADR

 SALES

 2,249

 172.1600 USD

 168.9200 USD

 

 

 

(b) Cash-settled derivative transactions

 

 Class of

relevant

security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per

unit

 ADR

 CFD

 LONG

 1,700

 169.8702 USD

 

 ADR

 CFD

 LONG

 2,070

 170.1748 USD

 

 ADR

 CFD

 LONG

 70

 170.2200 USD

 

 ADR

 CFD

 LONG

 300

 171.8900 USD

 

 ADR

 CFD

 LONG

 100

 171.9600 USD

 

 ADR

 CFD

 LONG

 100

 171.9600 USD

 

 ADR

 CFD

 SHORT

 600,000

 4.3000 USD

 

 ADR

 CFD

 SHORT

 1

 171.1300 USD

 

 ADR

 CFD

 SHORT

 1

 171.1300 USD

 

 5p ordinary

 CFD

 LONG

 88

 45.3440 GBP

 

 5p ordinary

 CFD

 LONG

 7,110

 45.4255 GBP

 

 5p ordinary

 CFD

 SHORT

 44

 45.2706 GBP

 

 5p ordinary

 CFD

 SHORT

 11,152

 45.4013 GBP

 

 5p ordinary

 CFD

 SHORT

 4,879

 45.4013 GBP

 

 5p ordinary

 CFD

 SHORT

 2,227

 45.4013 GBP

 

 5p ordinary

 CFD

 SHORT

 19,202

 45.4013 GBP

 

 5p ordinary

 CFD

 SHORT

 12,278

 45.4013 GBP

 

 5p ordinary

 CFD

 SHORT

 1,309

 45.4013 GBP

 

 5p ordinary

 CFD

 SHORT

 2,638

 45.4013 GBP

 

 5p ordinary

 CFD

 SHORT

 2,755

 45.4013 GBP

 

 5p ordinary

 CFD

 SHORT

 17,484

 45.4013 GBP

 

 5p ordinary

 CFD

 SHORT

 10,128

 45.4013 GBP

 

 5p ordinary

 CFD

 SHORT

 3,105

 45.4013 GBP

 

 5p ordinary

 CFD

 SHORT

 46,955

 45.4013 GBP

 

 5p ordinary

 CFD

 SHORT

 3,047

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 45,771

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 9,872

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 19,854

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 17,042

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 1,274

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 18,718

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 2,170

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 18,196

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 2,571

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 2,686

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 4,756

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 10,871

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 3,265

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 11,969

 45.5318 GBP

 

 5p ordinary

 CFD

 SHORT

 74

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 247

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 59

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 414

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 108

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 426

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 50

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 30

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 272

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 452

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 388

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 225

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 1,042

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 69

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 61

 45.6674 GBP

 

 5p ordinary

 CFD

 SHORT

 4,006

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 60,165

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 12,978

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 26,097

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 22,403

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 15,732

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 1,677

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 2,854

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 24,605

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 6,252

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 23,920

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 3,380

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 3,531

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 4,291

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 14,290

 45.7950 GBP

 

 5p ordinary

 CFD

 SHORT

 1,503

 45.2115 GBP

 

 5p ordinary

 CFD

 SHORT

 8,164

 46.2128 GBP

 

 5p ordinary

 CFD

 SHORT

 1,177

 57.0155 USD

 

 5p ordinary

 CFD

 SHORT

 28,823

 57.0155 USD

 

 5p ordinary

 CFD

 SHORT

 1,095

 57.1387 USD

 

 5p ordinary

 CFD

 SHORT

 1,642

 57.4384 USD

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of

relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 ADR

 CALL

 PURCHASE

 6,000

 180.0000

 A

 18/04/2019

 4.3000 USD

 

 

(ii) Exercise

 

 Class of

relevant

security

 Product description

e.g. call option

 Exercising/

exercised

against

 Number of securities

 Exercise price

per unit

 N/A

 N/A

 N/A

 N/A

 N/A  

 

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing

e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A  

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

 (b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

 Date of disclosure:

 19 DECEMBER 2018

 

 Contact name:

 Craig Horsley

 

 Telephone number:

 +44(141) 245 7736

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERFKCDNQBDDOBD
Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.